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SUMMARY

Following a single non-toxic i.p. injection with 0.5 or 1.0 mg

triethylenemelamine/kg a significant increase in chromosome aberrations in
mouse bone marrow was observed 6, 12, 30, but not 54 h after treatment.

A

single i.p. injection with 250 mg captan/kg caused up to 68% lethality above
controls, but no significant increase in chromosome aberrations after the
same time intervals.

One metacentric chromosome was observed 6, 30, and 54 h after

captan treatment among 300, 300, and 101 metaphase spreads respectively, whereas
none appeared in 1495 control spreads.
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INTRODUCTION

Captan is an extensively used fungicide known to produce base-pair
substitutions in Escherichia coli (1, 4, 8, 13), Salmonella typhimurium

(3, 7, 9, 17, 18), and Neurospora crassa (14, 15) and chromatid and chromosome
breaks in cell cultures (13).

Different studies using rats and mice gave

conflicting results with respect to dominant lethal mutations (5, 6, 12).

A

recent review of captan by Bridges (2) pointed out the need for additional information
on the possible genetic effects of captan in vivo.

This study reports results of bone marrow cytogenetic tests with captan in
mice.

The clastogenic alkylating agent, TEM, was used as positive control.

Abbreviations:

TEM, triethylenemelamine.
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MATERIALS AND METHODS

Animals and chemicals

Random bred Upjohn strain Swiss albino male mice weighing 25-40 g were used.

Captan 50 WP containing 50% technical captan lot # 01007-10, CAS # 133-06-2 was
obtained from the Stauffer Chemical Co. and TEM from Pfaltz and Bauer Inc.

Cytogenetic analysis of bone marrow metaphases

All chemicals were injected i.p. into four test groups of animals.

of the first group were injected with 1 ml of 0.9% saline.

Animals

The second group was

similarly injected with 250 mg captan/kg and the last two groups with 0.5 and 1
mg TEM/kg.

Animals from each treatment group were killed by cervical dislocation

at 6, 12, 30, and 54 h following injection.

Five h prior to killing, the animals

were injected i.p. with 1 mg/kg colchicine in 1 ml 0.9% saline.

With a 23 G

needle 1.5 ml of 2.2% sodium citrate was injected through each end of the excised

femurs.

The bone marrow cells were suspended and collected by centrifuging at

1000 rpm for 5 min.

in the test tube.

The supernatant was discarded leaving about 0.25 ml of fluid

The cells were thoroughly suspended and 3 ml of 37°C 0.56%

KC1 hypotonic solution was added and the suspension incubated in a water bath at

37°C.

In the last 5 min of the 30 min hypotonic treatment the cells were collected

as above.

Three ml fresh fixative (3 parts absolute methanol : 1 part glacial

acetic acid) was slowly added with constant agitation to prevent cell clumping.
Additional mixing was achieved with 5 aspirations.

three times.

The fixative was changed

During the last resuspension enough fixative was added to give a

turbid cell suspension.

Grease free microscope slides previously placed in a freezer were allowed
to collect condensation.

Three to four drops of cell suspension were placed
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on each slide and immediately passed through a flame allowing the methanol to
burn completely.

Once completely dry the slides were flooded for 4-5 min with

fresh Giemsa stain prepared by mixing 5 ml Giemsa stock solution, 6 ml acetone,

and 100 ml tap water.

Giemsa stock solution contained 3.6 q Giemsa powder

(Polysciences Inc.) dissolved in 250 ml glycerol and 250 ml methanol.
One hundred cells per animal were scored from randomized slides when

possible.

A gap was an achromatic lesion less than the width of a chromatid.

Gaps and isochromatid gaps were not scored separately.

as a single chromatid break.
multiple breaks.
Fig. 1

Fragments were scored

Cells with more than 10 breaks were scored as

A typical metaphase spread from control mice is shown in

.

Statistical analysis

The significance of differences in the frequencies of chromosome aberrations
with captan and TEM in comparison to the control was determined using the method

described by Kastenbaum and Bowmen (11).

RESULTS AND DISCUSSION

Toxicity

Shortly after injection of captan toxicity was noted.

Signs included edema,

decreased body temperature, sluggishness, and bluish skin color.

In 6, 12, 30,

and 54 h captan treatment lethality increased over control animals by 0, 25, 20,

and 68% respectively.

TEM treated animals showed no signs of toxicity.
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Time and concentration response

Six and 12 h following i.p. injection of 0.5 mg TEM/kg chromatid breaks
were predominant over chromosome breaks or rearrangements (Fig. 1

; Table I).

In agreement with the present results, in mice (10) and rat (16) bone marrow,
the most TEM-induced chromosome aberrations were detected 30 h

after treatment.

At this time interval a similar frequency of chromatid and chromosome type
aberrations were observed.

Predominance of chromatid breaks in metaphases

examined at the shortest intervals after treatment (6 and 12 h) indicates that

the majority of breaks were induced during the Go phase.

A similar frequency of

chromatid versus chromosome type aberrations (breaks, rearrangements, and rings)

at 30 h suggests that aberrations in both G-^ and G~ cells were induced (Table I) ,
One mg TEM/kg induced a higher percent of cells with aberrations at 12 and
30 h than 0.5 mg/kg.

The increase at 12 h was the greatest for rings and

rearrangements suggesting that the increased dose was more likely to induce
double-breaks necessary for these aberrations.

Fiftyfour h after treatment

chromosome damage was not observed with either dose indicating that TEM induced

aberrations cause cell lethality and/or are not transmitted (10, 16).
At no time did the incidence of chromosome aberrations in animals treated

with captan deviate significantly from the control (Table I).
metacentric chromosome (Fig. 1

However, one

) did appear at 6, 30, and 54 h in 1001 captan

treated metaphases, whereas none appeared in 1495 control spreads.

Because of

these unique chromosome rearrangements it cannot be determined with certainty

that 250 mg captan/kg i.p. does not break chromosomes in vivo.
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